Skip to content

Inhibrx Biosciences, Inc. INBX Business Segments — Other general and administrative

Similar metrics at other companies

Valvoline logo
VVVReportable Segment — Other general and administrative
$39.1M+9.8%
Immunovant, Inc. logo
IMVTReportable Segment — Other general and administrative
$7.14M-34.4%
Enphase Energy logo
ENPHReportable Segment — Other general and administrative
$20.35M-4.0%
Grindr logo
GRNDReportable Segment — Other general and administrative expense
$5.66M+44.2%
Archer Aviation logo
ACHRReportable Segment — Other general and administrative expense
$42.7M+105%
Veracyte logo
VCYTReportable Segment — Other general and administrative expenses
$13.47M-38.5%

Other financials

Income statement

See full
Revenue--100%
Operating income-$30.9M+27.9%
Net income-$33.4M+22.8%
EPS (diluted)-$2.15+23.2%

Balance sheet

See full
Cash & equivalents$161.7M-25.3%
Total debt$180.9M+69.8%
Total equity-$21.0M-122%
Total assets$184.0M-24.2%

Cash flow

See full
Operating cash flow-$38.0M-5.9%
CapEx--100%
Free cash flow-$38.0M-5.9%

Valuation

See full
Market cap$1.4B+385%
Enterprise value$1.42B+982%
P/S1,073.7×-280×

Profitability

See full
Operating margin-10,386.5%-5,025pp
Net margin-10,773.5%-878,492pp
FCF margin-9,986.5%-4,727pp

Returns & leverage

See full
Return on equity-197.8%-2,158pp
Debt / equity13.4×+13.3×
Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherGeneralAndAdministrativeExpense.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s business segments — other general and administrative.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s business segments — other general and administrative?
Inhibrx Biosciences, Inc. (INBX) reported business segments — other general and administrative of $2.06M in Q1 2026.
How has Inhibrx Biosciences, Inc.'s business segments — other general and administrative changed year-over-year?
Inhibrx Biosciences, Inc.'s business segments — other general and administrative decreased by 8.1% year-over-year, from $2.25M to $2.06M.
What is the long-term trend for Inhibrx Biosciences, Inc.'s business segments — other general and administrative?
Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s business segments — other general and administrative has grown at a -12.8% compound annual growth rate (CAGR), from $11.58M to $8.82M.
What does business segments — other general and administrative mean?
Captures general administrative and overhead expenses allocated to the segment that are not directly tied to research or manufacturing. It serves as a measure of the segment's operational efficiency and corporate support burden.